ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

CCOP Review Committees Listed

February 6, 1987

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal

January 12, 1990

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

September 24, 1999

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976